{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T21:09:44Z","timestamp":1784581784266,"version":"3.55.0"},"reference-count":42,"publisher":"SAGE Publications","issue":"12","license":[{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hum Exp Toxicol"],"published-print":{"date-parts":[[2002,12]]},"abstract":"<jats:p>\n                    This study compares the chronic toxicity of two anthracyclines\u2013daunorubicin and doxorubicin, commonly used for induction of anthracycline cardiomyopathy in the rabbit model. Such a comparative study has not been published until now. Both drugs were administered intravenously to male Chinchilla rabbits in doses at 3 mg\/ kg (50 mg\/m\n                    <jats:sup>2<\/jats:sup>\n                    ) once weekly for 10 weeks. Selected biochemical, haematological and cardiovascular parameters and body weights were regularly monitored; additionally, a histological evaluation of heart, kidney and liver was performed at the end of the experiment. In the daunorubicin group, there were marked signs of the progressive development of heart failure, like the significant increases of the pre-ejection period\/left ventricular ejection time index values (up to 134%)\u2013and histological changes within the myocardium were also observed. On the other hand, the 10-week doxorubicin administration did not cause these changes that are typical for heart injury. Haematotoxicity, manifested particularly by aplastic anaemia, was apparent in both the experimental groups. Significant body weight loss (by 45.2%) and high premature mortality (100% versus 36.4%) reflected a greater general toxicity, especially nephrotoxicity of doxorubicin in comparison with daunorubicin. Further studies are necessary to find a possible explanation for these findings.\n                  <\/jats:p>","DOI":"10.1191\/0960327102ht311oa","type":"journal-article","created":{"date-parts":[[2003,1,29]],"date-time":"2003-01-29T06:47:48Z","timestamp":1043822868000},"page":"649-657","source":"Crossref","is-referenced-by-count":35,"title":["Comparative study of chronic toxic effects of daunorubicin and doxorubicin in rabbits"],"prefix":"10.1177","volume":"21","author":[{"given":"Ivona","family":"Klimtov\u00e1","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology, Charles University in Prague,                         Faculty of Pharmacy in Hradec Kr\u00e1lov\u00e9,                         Heyrovsk\u00e1ho 1203, 500 05 Hradec Kr\u00e1lov\u00e9,                         Czech Republic;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1\u0161","family":"\u0160im\u016fnek","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Charles University in Prague,                         Faculty of Pharmacy in Hradec Kr\u00e1lov\u00e9, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvona","family":"Mazurov\u00e1","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Charles University in Prague, Faculty of                         Medicine in Hradec Kr\u00e1lov\u00e9, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radom\u00edr","family":"Hrdina","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Charles University in Prague,                         Faculty of Pharmacy in Hradec Kr\u00e1lov\u00e9, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladim\u00edr","family":"Ger\u0161","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Adamcov\u00e1","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Charles University in Prague, Faculty of                         Medicine in Hradec Kr\u00e1lov\u00e9, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2002,12,1]]},"reference":[{"key":"atypb1","unstructured":"Martindale W                 . The extra pharmacopoeia, 31st edition.                      London: Royal Pharmaceutical Society of Great Britain                 , 1996: 528\u2013531."},{"key":"atypb2","first-page":"75","volume":"43","author":"Hrdina R","year":"2000","journal-title":"Acta Med"},{"key":"atypb3","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200022040-00002"},{"key":"atypb4","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00003495-199856030-00009","volume":"56","author":"Wiseman LR","year":"1998","journal-title":"Drugs"},{"key":"atypb5","doi-asserted-by":"publisher","DOI":"10.1016\/S1058-9813(98)00002-2"},{"key":"atypb6","first-page":"15","volume":"4","author":"Herman EH","year":"1998","journal-title":"Semin Oncol"},{"key":"atypb7","doi-asserted-by":"publisher","DOI":"10.1191\/096032701680350604"},{"key":"atypb8","first-page":"903","volume":"15","author":"Maral R","year":"1967","journal-title":"Pathol Biol"},{"key":"atypb9","first-page":"997","volume":"39","author":"van Vleet JF","year":"1978","journal-title":"Am J Vet Res"},{"key":"atypb10","first-page":"85","volume":"31","author":"Herman EH","year":"1981","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"atypb11","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910450427"},{"key":"atypb12","doi-asserted-by":"publisher","DOI":"10.1007\/s002040050324"},{"key":"atypb13","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.1997.0588"},{"key":"atypb14","doi-asserted-by":"publisher","DOI":"10.1177\/096032719901800304"},{"key":"atypb15","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200000006-00008"},{"key":"atypb16","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(84)90044-0"},{"key":"atypb17","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-483X(99)00179-1"},{"key":"atypb18","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/16.1.147"},{"key":"atypb19","first-page":"395","volume":"66","author":"Deprez-DeCampeneere D","year":"1982","journal-title":"Cancer Treat Rep"},{"key":"atypb20","first-page":"1462","volume":"41","author":"van Fvleet JF","year":"1980","journal-title":"Am J Vet Res"},{"key":"atypb21","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-197001000-00002"},{"key":"atypb22","first-page":"292","volume":"30","author":"Jaenke RS","year":"1974","journal-title":"Lab Invest"},{"key":"atypb23","first-page":"911","volume":"62","author":"Long HJ","year":"1978","journal-title":"Cancer Treat Rep"},{"key":"atypb24","unstructured":"Ganong WF                 . Review of medical physiology.                      New York: McGraw-Hill                 , 1999: 542-542."},{"key":"atypb25","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2828(86)80409-6"},{"key":"atypb26","doi-asserted-by":"publisher","DOI":"10.1159\/000226952"},{"key":"atypb27","first-page":"157","volume":"45","author":"Bristow MR","year":"1981","journal-title":"Lab Invest"},{"key":"atypb28","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/19.6.378"},{"key":"atypb29","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/24.7.591"},{"key":"atypb30","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.1997.0494"},{"key":"atypb31","doi-asserted-by":"publisher","DOI":"10.1253\/jcj.61.249"},{"key":"atypb32","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4274(83)90109-1"},{"key":"atypb33","first-page":"331","volume":"191","author":"Bachur NR","year":"1974","journal-title":"J Pharmacol Exp Ther"},{"key":"atypb34","doi-asserted-by":"publisher","DOI":"10.1191\/096032701682693026"},{"key":"atypb35","first-page":"127","volume":"19","author":"Hutchison FN","year":"1993","journal-title":"Miner Electrolyte Metab"},{"key":"atypb36","first-page":"159","volume":"6","author":"Young DM","year":"1975","journal-title":"Cancer Chemother Rep"},{"key":"atypb37","doi-asserted-by":"publisher","DOI":"10.1007\/BF00389569"},{"key":"atypb38","first-page":"242","volume":"43","author":"Fajardo LF","year":"1980","journal-title":"Lab Invest"},{"key":"atypb39","first-page":"64","volume":"13","author":"Falkson G","year":"1985","journal-title":"Exp Hematol"},{"key":"atypb40","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-198704000-00053"},{"key":"atypb41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.1992.tb00352.x"},{"key":"atypb42","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-263620-2.50014-8"}],"container-title":["Human &amp; Experimental Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1191\/0960327102ht311oa","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1191\/0960327102ht311oa","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:48:15Z","timestamp":1777448895000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1191\/0960327102ht311oa"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2002,12]]}},"alternative-id":["10.1191\/0960327102ht311oa"],"URL":"https:\/\/doi.org\/10.1191\/0960327102ht311oa","relation":{},"ISSN":["0960-3271","1477-0903"],"issn-type":[{"value":"0960-3271","type":"print"},{"value":"1477-0903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,12]]}}}